martes, 27 de febrero de 2018

Opioids Update February 2018

Centers for Disease Control and Prevention. Your online source for credible health information.

Recent Articles and Publications

Postincarceration Fatal Overdoses After Implementing Medications for Addiction Treatment in a Statewide Correctional System: This article provides outcome data from a preliminary evaluation of a comprehensive Medication-Assisted Treatment (MAT) program implemented within the Rhode Island Department of Corrections. Results indicate that this effort led to a 60.5% reduction in mortality between 2016 and 2017, suggesting the benefit of such programs to states looking to address overdose deaths among criminal justice-involved populations.
Effect of a High Dosage Opioid Prior Authorization Policy on Prescription Opioid: New CDC funded study looks at the 2012 Oregon Medicaid program prior authorization policy for opioid prescriptions above 120 mg per day. This study evaluated the effects of that policy on utilization, prescribing patterns, and health outcomes by looking at claims data from 2011-2013. Oregon’s prior authorization policy was effective at reducing fills of high dosage opioid prescriptions, which is a risk factor for opioid-involved overdoses.
Alcohol Screening and Brief Intervention For People Who Consume Alcohol and Use Opioids:Excessive drinkers who use opioid pain relievers are at greater risk of overdose and death due to the depressant effects of alcohol on the respiratory system and central nervous system. In fact, alcohol was involved in 22% of deaths caused by opioid pain relievers and 18% of emergency department visits related to the misuse of opioid pain relievers in the United States in 2010. Screening and brief intervention for excessive alcohol use (ASBI) is an evidence based strategy that can be used by clinicians to help people who drink excessively and who may be prescribed an opioid for pain relief to drink less, or stop drinking altogether, while using opioid medications.
Alcohol and opioids
Preparing for 2018 RxSummit
The National Rx Drug Abuse & Heroin Summit is the annual gathering for stakeholders to discuss what is working in prevention and treatment. Be part of the international discussion on addressing the opioid crisis by attending the 2018 National Rx Drug Abuse & Heroin Summit in Atlanta from April 2-5, 2018. Registration is now open.
New WISQARS Data Visualization
The new WISQARS Data Visualization displays fatal injury data in a new interactive, visual format. You can explore injury death data from 1999 to 2016. WISQARS Data Visualization provides new capabilities for Injury data analysis, comprehension, and communication:
  • Analyze injury data patterns: View trends in charts and graphs.
  • Comprehend injury data quickly: Use visualizations to see large amounts of data in clear cohesive ways.
  • Communicate injury data visually: Share new insights and communicate findings in charts, graphs, and maps.
Newest Opioid Training for Providers: Reducing the Risks of Opioids
CDC recently launched a new opioid training for providers (Reducing the Risks of Opioids), the fourth module of a series of interactive online trainings. Healthcare providers will learn to recognize situations that can increase risk for harmful outcomes for patients on opioid therapy and explain the range of clinical tools that can help in risk assessment and clinical decision-making, such as prescription drug monitoring program (PDMP) data and urine drug testing (UDT). The training also features recommendations from theCDC Guideline for Prescribing Opioids for Chronic Pain and provides sample scenarios and clinical tools and resources. This training is part of a series that is available for free continuing education credit and is located on our Training for Providers webpage.
Applying CDC's Guideline for Prescribing Opioids
CDC’s Injury Center intends to commit approximately $3,000,000 over a 4-year project period with a maximum of $750,000 per year. This funding will support one application to better understand how reducing the dose or stopping the use of opioids and benzodiazepines can reduce injury and improve safety in older adult patients. Specifically, the research will evaluate the effectiveness of medication tapering and discontinuation strategies to reduce falls and unintentional injury among older adults. The purpose is to advance knowledge about how health professionals can improve prescribing practices for medications in which the risks may outweigh the benefits, contributing to falls, overdose, and other injuries in community dwelling older adults.
For healthcare providers, this research will develop evidence-based strategies that can be easily integrated into the work flow and can be adopted to taper and/or discontinue opioids, benzodiazepines, and other CNS-active medications and improve patient safety. Additionally, the research could be used to inform future trainings and provider education.
Important Dates
  • Letter of Intent Due: 01/30/2018
  • Application Due: 03/23/2018
The funding opportunity announcement can be found at that amendments to the announcement focus and application dates are possible. Please check for updates on
NIJ's drugs and crime portfolio supports research on law enforcement efforts to deter, investigate, prosecute, and address illegal drug trafficking, markets, and use. This FY2018 solicitation will seek investigator-initiated proposals to conduct applied research on evidence-based tools, protocols, and policies for State, local and tribal jurisdictions. The two drug priorities are: 1) opioid-related criminal investigation, prosecution, drug intelligence, and community surveillance; and 2) illegal marijuana markets and drug-related violent crime. Opioid research proposals should address narcotics law enforcement, forensic science, and/or medicolegal death investigations; and opioids include heroin, fentanyl, diverted pharmaceuticals, synthetic drugs, and analogues.
Important Dates
  • Application Due: 4/25/2018
General information on applying for NIJ awards can be found at Answers to frequently asked questions that may assist applicants are posted For assistance with any other requirements of this solicitation (NIJ-2018-13682): toll-free at 1-800-851-3420; via TTY at 301-240-6310 (hearing impaired only);; fax to 301-240-5830; or web chat at
Webinar - Coordination Clinical and Public Health Responses to Opioid Overdoses Treated in Emergency Departments
On March 13 (2-3:30 pm ET), CDC will host a webinar “Coordinating Clinical and Public Health Responses to Opioid Overdoses Treated in Emergency Departments,” featuring the U.S. Surgeon General, Acting CDC Director, CDC behavioral scientists, and experts from Rhode Island.

No hay comentarios:

Publicar un comentario